| Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis Y Ergun, G Ucar, B Akagunduz Cancer treatment reviews 115, 102538, 2023 | 20 | 2023 |
| Impact of coronaphobia on treatment and follow-up compliance of cancer patients B Akagunduz, M Ozer, C Karacin, MM Atcı, HC Yıldırım, E Unver Future Oncology 17 (20), 2621-2629, 2021 | 16 | 2021 |
| Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy C Karacin, B Oksuzoglu, A Demirci, M Keskinkılıç, NK Baytemür, F Yılmaz, ... BMC cancer 23 (1), 136, 2023 | 11 | 2023 |
| Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey MB Hacıoğlu, O Köstek, S Karabulut, D Taştekin, S Sezgin Göksu, ... Journal of BU ON., 2020 | 11 | 2020 |
| Dynamic changes in systemic immune‐inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer … NC Demircan, MM Atcı, M Demir, S Işık, B Akagündüz Asia‐Pacific Journal of Clinical Oncology 19 (1), 104-112, 2023 | 10 | 2023 |
| Controlling nutritional status (CONUT) score is a prognostic factor for patients with gastric cancer treated by perioperative FLOT B Akagunduz, M Demir, MM Atcı Journal of Gastrointestinal Cancer, 1-10, 2022 | 8 | 2022 |
| Protective effects of taxifolin on pazopanib-induced liver toxicity: an experimental rat model B Akagunduz, M Ozer, F Ozcıcek, AV Kara, S LAcın, M Özkaraca, ... Experimental animals 70 (2), 169-176, 2021 | 8 | 2021 |
| Adoptive cell therapy in hepatocellular carcinoma: A review of clinical trials M Ozer, SY Goksu, B Akagunduz, A George, I Sahin Cancers 15 (6), 1808, 2023 | 7 | 2023 |
| Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients A Rembielak, T Yau, B Akagunduz, S Aspeslagh, G Colloca, A Conway, ... Journal of Geriatric Oncology, 101502, 2023 | 6 | 2023 |
| Systemic treatment for triple negative breast cancer in older patients: A Young International Society of Geriatric Oncology Review Paper WL Chan, J Marinho, Y Chavarri-Guerra, J Hincapie-Echeverri, ... Journal of Geriatric Oncology 13 (5), 563-571, 2022 | 6 | 2022 |
| Effects of adenosine triphosphate on vandetanib induced skin damage in rats B Akagunduz, F Ozcicek, AV Kara, DC Guven, GN Yazici, A Coban, ... Cutaneous and Ocular Toxicology 39 (4), 323-327, 2020 | 5 | 2020 |
| The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification?(Turkish Oncology … M Hizal, B Bilgin, N Paksoy, MM Atcı, S Kahraman, S Kılıçkap, DC Güven, ... Journal of Cancer Research and Clinical Oncology 149 (8), 4141-4148, 2023 | 4 | 2023 |
| The risk of malnutrition and its clinical implications in older patients with cancer Z Sucuoglu Isleyen, M Besiroglu, AI Yasin, M Simsek, A Topcu, L Smith, ... Aging Clinical and Experimental Research 35 (11), 2675-2683, 2023 | 3 | 2023 |
| First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer SA Esen, Y Ergun, C Erol, R Arikan, MM Er, MM Atci, A Topçu, G Uçar, ... Bosnian journal of basic medical sciences 22 (5), 818, 2022 | 3 | 2022 |
| The prognostic value of postoperative lymph node ratio in gastric adenocarcinoma patients treated with neoadjuvant chemotherapy A Sakin, MM Atci, MN Aldemir, B Akagündüz, S Şahin, S Arıcı, S Secmeler, ... Cureus 13 (4), 2021 | 3 | 2021 |
| Evaluation of the correlation of urea, creatine, and uric acid levels with TSH in patients with newly diagnosed overt and subclinic hypothyroidism B Akagunduz, M Akcakaya Eurasian Journal of Medical Investigation 5 (3), 317-321, 2021 | 3 | 2021 |
| The effect of HER2-low status on pathological complete response and survival in triple-negative breast cancer: a systemic review and meta-analysis Y Ergun, B Akagunduz, C Karacin, S Turker, G Ucar Clinical Breast Cancer, 2023 | 2 | 2023 |
| Effect of adjuvant chemotherapy in stage III cervical cancer patients treated with concurrent chemoradiation: A multicenter study MM Atci, B Akagunduz, M Demir, B Dönmez Yilmaz, T Akin Telli, O Can, ... Oncology Research and Treatment 45 (5), 254-261, 2022 | 2 | 2022 |
| Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study I Cil, A Kucukarda, MM Atcı, S Secmeler, N Paksoy, F Ferhatoglu, N Ak, ... Tumori Journal 108 (1), 19-25, 2022 | 2 | 2022 |
| Assessment of abuse and related factors in older patients with cancer B Akagunduz, Z Altın, MM Atcı, M Ozer, DC Güven, İ Çil, F Özçiçek, ... Supportive care in cancer 29 (12), 7957-7964, 2021 | 2 | 2021 |
